av/sernova--big.svg

NASDAQ:SVA

Sinovac Biotech, Ltd

  • Stock

USD

Last Close

6.47

28/08 20:00

Market Cap

464.94M

Beta: -

PE Ratio

5.65

PFCF: −0.40

  • locale

    usUnited States
  • market

    STOCKS
  • industry

    Biotechnology
  • website

    www.sinovac.com
  • ipo date

    Sep 26, 2003

Sinovac Biotech Ltd is a China-based biopharmaceutical company that focuses on research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases including, without limitation, hepatitis A, hepatitis B, hand foot and mouth disease (HFMD) caused by EV71, seasonal influenza, H5N1 and H1N1 pandemic influenza, coronavirus, pneumoco...Show More

peer of

Earnings

Earnings per Share (Estimate*)

204060801001202012-12-312014-12-312016-12-312019-07-102021-04-22

Revenue (Estimate*)

5B10B15B20B2012-12-312014-12-312016-12-312019-07-102021-04-22

*Estimate based on analyst consensus